Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials

Abstract

INTRODUCTION Adjunctive mealtime use of the amylin analog pramlintide improves postprandial hyperglycemia in patients with type 1 diabetes. This post hoc analysis of three randomized trials evaluated whether disease duration affected responses to pramlintide. METHODS Patients received mealtime pramlintide 30 or 60 µg (n = 714) or placebo (n = 537) as an… (More)
DOI: 10.1007/s12325-016-0326-5

5 Figures and Tables

Topics

  • Presentations referencing similar topics